240 related articles for article (PubMed ID: 35552788)
1. Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.
Bouglé A; Tuffet S; Federici L; Leone M; Monsel A; Dessalle T; Amour J; Dahyot-Fizelier C; Barbier F; Luyt CE; Langeron O; Cholley B; Pottecher J; Hissem T; Lefrant JY; Veber B; Legrand M; Demoule A; Kalfon P; Constantin JM; Rousseau A; Simon T; Foucrier A;
Intensive Care Med; 2022 Jul; 48(7):841-849. PubMed ID: 35552788
[TBL] [Abstract][Full Text] [Related]
2. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
3. Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial.
Foucrier A; Dessalle T; Tuffet S; Federici L; Dahyot-Fizelier C; Barbier F; Pottecher J; Monsel A; Hissem T; Lefrant JY; Demoule A; Constantin JM; Rousseau A; Simon T; Leone M; Bouglé A;
Crit Care; 2023 May; 27(1):211. PubMed ID: 37254209
[TBL] [Abstract][Full Text] [Related]
4. Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial.
Mo Y; Booraphun S; Li AY; Domthong P; Kayastha G; Lau YH; Chetchotisakd P; Limmathurotsakul D; Tambyah PA; Cooper BS;
Lancet Respir Med; 2024 May; 12(5):399-408. PubMed ID: 38272050
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study.
Nseir S; Favory R; Jozefowicz E; Decamps F; Dewavrin F; Brunin G; Di Pompeo C; Mathieu D; Durocher A;
Crit Care; 2008; 12(3):R62. PubMed ID: 18454864
[TBL] [Abstract][Full Text] [Related]
6. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.
Chastre J; Wolff M; Fagon JY; Chevret S; Thomas F; Wermert D; Clementi E; Gonzalez J; Jusserand D; Asfar P; Perrin D; Fieux F; Aubas S;
JAMA; 2003 Nov; 290(19):2588-98. PubMed ID: 14625336
[TBL] [Abstract][Full Text] [Related]
8. Duration of Antibiotic Therapy for Early VAP Trial: Study Protocol for a Surgical Infection Society Multicenter, Pragmatic, Randomized Clinical Trial of Four versus Seven Days of Definitive Antibiotic Therapy for Early Ventilator-Associated Pneumonia in Surgical Patients.
Meizoso JP; Sauaia A; Namias N; Manning RJ; Pieracci FM
Surg Infect (Larchmt); 2023 Mar; 24(2):163-168. PubMed ID: 36730717
[No Abstract] [Full Text] [Related]
9. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
[TBL] [Abstract][Full Text] [Related]
10. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial.
Yoshimura J; Yamakawa K; Kinoshita T; Ohta Y; Morimoto T
Trials; 2018 Nov; 19(1):614. PubMed ID: 30409160
[TBL] [Abstract][Full Text] [Related]
11. Reinventing the wheel: Impact of prolonged antibiotic exposure on multidrug-resistant ventilator-associated pneumonia in trauma patients.
Lewis RH; Sharpe JP; Swanson JM; Fabian TC; Croce MA; Magnotti LJ
J Trauma Acute Care Surg; 2018 Aug; 85(2):256-262. PubMed ID: 29664891
[TBL] [Abstract][Full Text] [Related]
12. Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial.
Mo Y; West TE; MacLaren G; Booraphun S; Li AY; Kayastha G; Lau YH; Chew YT; Chetchotisakd P; Tambyah PA; Limmathurotsakul D; Cooper B
BMJ Open; 2021 May; 11(5):e050105. PubMed ID: 33986070
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant Pseudomonas aeruginosa and mortality in mechanically ventilated ICU patients.
Denis JB; Lehingue S; Pauly V; Cassir N; Gainnier M; Léone M; Daviet F; Coiffard B; Baron S; Guervilly C; Forel JM; Roch A; Papazian L
Am J Infect Control; 2019 Sep; 47(9):1059-1064. PubMed ID: 30962023
[TBL] [Abstract][Full Text] [Related]
14. Short-course versus prolonged-course antibiotic regimens for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials.
Cheema HA; Ellahi A; Hussain HU; Kashif H; Adil M; Kumar D; Shahid A; Ehsan M; Singh H; Duric N; Szakmany T
J Crit Care; 2023 Dec; 78():154346. PubMed ID: 37247528
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a short versus long-course antibiotic therapy for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials.
Daghmouri MA; Dudoignon E; Chaouch MA; Baekgaard J; Bougle A; Leone M; Deniau B; Depret F
EClinicalMedicine; 2023 Apr; 58():101880. PubMed ID: 36911269
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
[TBL] [Abstract][Full Text] [Related]
17. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Intensive Care Med; 2006 Dec; 32(12):1970-8. PubMed ID: 16957901
[TBL] [Abstract][Full Text] [Related]
18. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
[TBL] [Abstract][Full Text] [Related]
19. Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.
Raineri E; Crema L; Dal Zoppo S; Acquarolo A; Pan A; Carnevale G; Albertario F; Candiani A
Eur J Clin Microbiol Infect Dis; 2010 Aug; 29(8):1015-24. PubMed ID: 20524138
[TBL] [Abstract][Full Text] [Related]
20. Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.
Kaminski C; Timsit JF; Dubois Y; Zahar JR; Garrouste-Orgeas M; Vesin A; Azoulay E; Feger C; Dumenil AS; Adrie C; Cohen Y; Allaouchiche B;
Crit Care; 2011; 15(2):R112. PubMed ID: 21481266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
